Vitamin D: Beyond bone

Annals of the New York Academy of Sciences

Volumn 1287, Issue 1, 2013, Pages 45-58

  Christakos, Sylvia ^a   Hewison, Martin ^b   Gardner, David G ^c   Wagner, Carol L ^d   Sergeev, Igor N ^e   Rutten, Erica ^f   Pittas, Anastassios G ^g   Boland, Ricardo ^h   Ferrucci, Luigi ⁱ   Bikle, Daniel D ^j  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e SOUTH DAKOTA STATE UNIVERSITY   (United States)

^f CIRO Center of Expertise for Chronic Organ Failure   (Netherlands)

^g TUFTS MEDICAL CENTER   (United States)

^h UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

ⁱ NATIONAL INSTITUTE ON AGING   (United States)

^j VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

Aging; Cancer; Cognitive function; Diabetes; Immunity; Muscle; Obesity; Pregnancy; Pulmonary disease; Vitamin D

Indexed keywords

COLECALCIFEROL; HEMATOLOGIC AGENT; VITAMIN D; VITAMIN D RECEPTOR;

AGING; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COGNITION; DIABETES MELLITUS; DIETARY INTAKE; ERYTHROPOIESIS; GENOME; HEALTH CARE POLICY; HEMODIALYSIS; HUMAN; IMMUNITY; IMMUNOMODULATION; KIDNEY FAILURE; LACTATION; LUNG FUNCTION; MUSCLE FUNCTION; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PREGNANCY; PROPHYLAXIS; VITAMIN D DEFICIENCY;

EID: 84878454194     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12129     Document Type: Article

References (60)

1. Christakos, S. & H.F. DeLuca 2011. Minireview: Vitamin D: is there a role in extraskeletal health? Endocrinology 152: 2930-2936.
2. Dhawan, P., R. Wieder & S. Christakos 2009. CCATT enhancer binding protein alpha is a molecular target of 1, 25-dihydroxyvitamin D3 in MCF-7 breast cancer cells. J. Biol. Chem. 284: 3086-3095.
3. Joshi, S., L.-C. Pantalena, X. K. Liu, et al. 2011. 1, 25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol. Cell. Biol. 31: 3653-3669.
4. Liu, P.T. et al. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
5. Hewison, M. 2011. Antibacterial effects of vitamin D. Nat. Rev. Endocrinol. 7: 337-345.
6. Hewison, M. et al. 2003. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 170: 5382-5390.
7. Jeffery, L.E. et al. 2012. Availability of 25-Hydroxyvitamin D3 to APCs Controls the Balance between Regulatory and Inflammatory T Cell Responses. J. Immunol. 189: 5155-5164.
8. rd Edition. D.J.W. Feldman, Pike and J.S. Adams, eds: 541-563. Elsevier: New York.
9. Li, Y.C., J. Kong, M. Wei, et al. 2002. 1, 25-dihydroxyvitamin D(3) is a Negative Endocrine Regulator of the Renin-Angiotensin System. J. Clin. Invest. 110: 229-238.
10. Chen, S. & D.G. Gardner Liganded Vitamin D Receptor Displays Anti-Hypertrophic Activity in the Murine Heart. J. Steroid. Biochem. Mol. Biol., in press.
11. Chen, S., C.S. Law, C.L. Grigsby, et al. 2011. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation 124: 1838-1847.
12. Hollis, B.W., D. Johnson, T.C. Hulsey, et al. 2011. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J. Bone. Miner. 26(10): 2341-2357. PMCID: 3183324.
13. Mahomed, K. & A.M. Gulmezoglu 1999. Vitamin D supplementation in pregnancy (Cochrane Review). Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd. Chicester, UK.
14. De-Regil, L.M., C. Palacios, A. Ansary, et al. 2012. Vitamin D supplementation for women during pregnancy. Cochrane Database of Systematic Reviews 2: CD008873.
15. Hollis, B.W. & C.L. Wagner 2012. Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif. Tissue. Int.
16. Wagner, C.L., R. McNeil, S.A. Hamilton, et al. 2012. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am. J. Obstet. Gynecol.
17. Wagner, C.L., T.C. Hulsey, D. Fanning, et al. 2006. High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeed Med. 1: 59-70.
18. Wagner, C.L., C. Howard, T.C. Hulsey, et al. 2012. Preliminary Results of a Randomized Controlled Trial of Maternal Supplementation with 6400 IU Vitamin D/day Compared with Maternal & Infant Supplementation of 400 IU/day in Achieving Sufficiency in the Breastfeeding Mother-Infant Dyad. Intl. Society Res. Human Milk Lactation. in press (abstract).
19. Sergeev, I.N. 2009. Novel mediators of vitamin D signaling in cancer and obesity. Immun. Endoc. Metab. Agents Med. Chem. 9: 153-158.
20. Song, Q. & I.N. Sergeev 2012. Calcium and vitamin D in obesity. Nutr. Res. Rev. 25: 130-141.
21. Sergeev, I.N. 2012. Vitamin D and cellular Ca2+ signaling in breast cancer. Anticancer Res. 32: 299-302.
22. Sergeev, I.N. 2005. Calcium signaling in cancer and vitamin D. J. Steroid Biochem. Mol. Biol. 97: 145-151.
23. 2+-mediated apoptosis in adipocytes via activation of calpain and caspase-12. Biochem. Biophys. Res. Commun. 384: 18-24.
24. Janssens, W. et al. 2009. Vitamin D Beyond Bones in COPD: Time to Act. Am. J. Respir Crit. Care Med.
25. Janssens, W. et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax. 65(3): 215-220.
26. Romme, E.A. et al. 2012. Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease. Ann. Med.
27. Persson, L.J. et al. 2012. Chronic obstructive pulmonary disease is associated with low levels of vitamin d. PLoS One 7(6): e38934.
28. Forli, L. et al. 2004. Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J. Intern. Med. 256(1): 56-62.
29. Hopkinson, N.S. et al. 2008. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am. J. Clin. Nutr. 87(2): 385-390.
30. Lehouck, A. et al. 2012. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med. 156(2): 105-114.
31. Black, P.N. & R. Scragg 2005. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 128(6): 3792-3798.
32. Kumar, V.A., D.A. Kujubu, J.J. Sim, et al. 2011. Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients. J. Nephrol. 24(1): 98-105.
33. Andrews, N.C. 2004. Anemia of inflammation:the cytokine-hepcidin link. J. Clin. Invest. 113(9): 1251-1253.
34. Howick, J., P. Glasziou & J.K. Aronson 2009. The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute? J. Royal Soc. Med. 102: 186-194.
35. Mitri, J., M.D. Muraru & A.G. Pittas 2011. Vitamin D and type 2 diabetes: a systematic review. Eur. J. Clin. Nutr. 65: 1005-1015.
36. Song, Y., L. Wang, A.G. Pittas, et al. Blood 25-hydroxyvitamin D concentration and incident Type 2 Diabetes: A meta-analysis of prospective studies diabetes care (in press).
37. Pittas, A.G. et al. 2007. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 30: 980-986.
38. von Hurst, P.R. et al. 2008. Study protocol-metabolic syndrome, vitamin D and bone status in South Asian women living in Auckland, New Zealand: a randomised, placebo-controlled, double-blind vitamin D intervention. BMC Public Health 8: 267.
39. Mitri, J. et al. 2011. Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the calcium and vitamin D for diabetes mellitus (CaDDM) randomized controlled trial. Am. J. Clin. Nutr. 94: 486-494.
40. Boland, R. 1986. Role of vitamin D in skeletal muscle function. Endocr. Rev. 7: 434-448.
41. Gallagher, J.C. 2004. The effects of calcitriol on falls and fractures and physical performance tests. J. Steroid Biochem. Mol. Biol. 89-90: 497-501.
42. Bischoff, H.A., M. Borchers, F. Gudat, et al. 2001. In situ detection of 1, 25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem. J. 33: 19-24.
43. Boland, R. 2005. Vitamin D and Muscle. In: Vitamin D. 2nd. Edition; D. Feldman, G. Glorieux & W. Pike, eds: 885-898. Academic Press. CA, USA. Chapter 55.
44. Boland, R. 2011. VDR activation of intracellular signaling pathways in skeletal muscle. Mol. Cell. Endocrinol. 34: 11-16.
45. Boland, R., A.R. de Boland, C. Buitrago, et al. 2002. Non-genomic stimulation of tyrosine phosphorylation cascades by 1, 25(OH)2D3 by VDR-dependent and -independent mechanisms in muscle cells. Steroids 67: 477-482.
46. Capiati, D., S. Benassati & R. Boland 2002. 1, 25(OH)2-vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells. J. Cell. Biochem. 86: 128-135.
47. Houston, D.K., R.H. Neiberg, J.A. Tooze, et al. 2013. Low 25-hydroxyvitamin D predicts the onset of mobility limitation and disability in community-dwelling older adults: The health ABC study. J. Gerontol. A Biol. Sci. Med. Sci. 68(2): 181-187.
48. Rock, C.L., J.A. Emond, S.W. Flatt, et al. 2012. Weight loss is associated with increased serum 25-hydroxyvitamin D in overweight or obese women. Obesity. 20(11): 2296-2301.
49. Visser, M., D.J. Deeg, P. Lips, Longitudinal Aging Study Amsterdam. 2003. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the longitudinal aging study amsterdam. J. Clin. Endocrinol. Metab. 88(12): 5766-5772.
50. Giallauria, F., Y. Milaneschi, T. Tanaka, et al. 2012. Arterial stiffness and vitamin D levels: the Baltimore longitudinal study of aging. J. Clin. Endocrinol. Metab. 97(10): 3717-3723.
51. Silvagno, F., E. De Vivo, A. Attanasio, et al. 2010. Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes. PLoS One. 5(1): e8670.
52. Krishnan, A.V. & D. Feldman 2011. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu. Rev. Pharmacol. Toxicol. 51: 311-336.
53. Llewellyn, D.J., I.A. Lang, K.M. Langa, et al. 2010. Vitamin D and risk of cognitive decline in elderly persons. Arch. Intern. Med. 170(13): 1135-1141.
54. Milaneschi, Y., M. Shardell, A.M. Corsi, et al. 2010. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J. Clin. Endocrinol. Metab. 95(7): 3225-3233.
55. Institute of Medicine. 2011. Dietary reference intakes for calcim and vitamin D. Washington DC: The National Academies Press.
56. Holick, M.F., N.C. Binkley, H.A. Bischoff-Ferrari, et al. 2011. Evaluation, treatment and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 96: 1911-1930
57. Looker, A.C., C.L. Johnson, D.A. Lacher, et al. 2011. Vitamin D status: United States, 2001-2006. National Center for Health Statistics Data Brief no 59.
58. Kuchuk, N.O., N.M. van Schoor, S.M. Pluijm, et al. 2009. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J. Bone. Min. Res. 24: 693-701.
59. Binkley, N., D.C. Krueger, S. Morgan & D. Wiebe 2010. Current status of clinical 25-hydroxyvitamin D measurement: an assessment of between-laboratory agreement. Clin. Chim. Acta. 411: 1976-1982
60. Christakos, S., P. Dhawan, Y. Liu, et al. 2003. New Insights into the mechanisms of vitamin D action. J. Cell. Biochem. 88: 695-705.